These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6471932)

  • 1. Elemental profiles of blood cells in certain neurological disorders.
    Johansson E; Lindh U; Alanen T; Westermarck T; Heiskala H; Santavuori P; Elovaara I
    Med Biol; 1984; 62(2):139-42. PubMed ID: 6471932
    [No Abstract]   [Full Text] [Related]  

  • 2. Altered elemental profiles in neuronal ceroid lipofuscinosis.
    Johansson E; Lindh U; Westermarck T; Heiskala H; Santavuori P
    J Trace Elem Electrolytes Health Dis; 1990 Sep; 4(3):139-42. PubMed ID: 2136129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant therapy in neuronal ceroid-lipofuscinosis.
    Santavuori P; Westermarck T
    Med Biol; 1984; 62(2):152-3. PubMed ID: 6471935
    [No Abstract]   [Full Text] [Related]  

  • 4. Principles of antioxidant therapy in neuronal ceroid lipofuscinosis.
    Westermarck T; Santavuori P
    Med Biol; 1984; 62(2):148-51. PubMed ID: 6471934
    [No Abstract]   [Full Text] [Related]  

  • 5. Charting the effects of antioxidant therapy in the diseased brain: focus on "vitamin E deficiency and metabolic deficits in neuronal ceroid lipofuscinosis described by bioinformatics".
    Järvelä I; Glueck SB
    Physiol Genomics; 2002 Dec; 11(3):183-4. PubMed ID: 12464692
    [No Abstract]   [Full Text] [Related]  

  • 6. You say lipofuscin, we say ceroid: defining autofluorescent storage material.
    Seehafer SS; Pearce DA
    Neurobiol Aging; 2006 Apr; 27(4):576-88. PubMed ID: 16455164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin ineffective in neuronal ceroid lipofuscinosis patients with fragmented or normal motor activity rhythms recorded by wrist actigraphy.
    Hätönen T; Kirveskari E; Heiskala H; Sainio K; Laakso ML; Santavuori P
    Mol Genet Metab; 1999 Apr; 66(4):401-6. PubMed ID: 10191137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosomal ceroid depletion by drugs: therapeutic implications for a hereditary neurodegenerative disease of childhood.
    Zhang Z; Butler JD; Levin SW; Wisniewski KE; Brooks SS; Mukherjee AB
    Nat Med; 2001 Apr; 7(4):478-84. PubMed ID: 11283676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free radicals, anticonvulsants, and the neuronal ceroid-lipofuscinoses.
    Maertens P; Dyken P; Graf W; Pippenger C; Chronister R; Shah A
    Am J Med Genet; 1995 Jun; 57(2):225-8. PubMed ID: 7668334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural and extraneural expression of the neuronal ceroid lipofuscinoses genes CLN1, CLN2, and CLN3: functional implications for CLN3.
    Chattopadhyay S; Pearce DA
    Mol Genet Metab; 2000; 71(1-2):207-11. PubMed ID: 11001812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent prednisolone and autoantibodies to GAD65 in juvenile neuronal ceroid lipofuscinosis.
    Aberg L; Talling M; Härkönen T; Lönnqvist T; Knip M; Alen R; Rantala H; Tyynelä J
    Neurology; 2008 Apr; 70(14):1218-20. PubMed ID: 18378887
    [No Abstract]   [Full Text] [Related]  

  • 12. Progress in neuropathology of the neuronal ceroid lipofuscinoses.
    Goebel HH; Schochet SS; Jaynes M; Brück W; Kohlschütter A; Hentati F
    Mol Genet Metab; 1999 Apr; 66(4):367-72. PubMed ID: 10191130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult onset thalamocerebellar degeneration in dogs associated to neuronal storage of ceroid lipopigment.
    Sisó S; Navarro C; Hanzlícek D; Vandevelde M
    Acta Neuropathol; 2004 Nov; 108(5):386-92. PubMed ID: 15365721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palmitate oxidation in muscle mitochondria of patients with the juvenile form of neuronal ceroid-lipofuscinosis.
    Majander A; Pihko H; Santavuori P
    Am J Med Genet; 1995 Jun; 57(2):298-300. PubMed ID: 7668349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Localization of catecholamines, serotonin, histamine and acetylcholinesterase in human peripheral blood structures].
    Teniukov VV; Gordon DS
    Arkh Anat Gistol Embriol; 1984 Nov; 87(11):78-81. PubMed ID: 6525045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurological aspects of ceroid-lipofuscinoses].
    Peña JA; Cardozo J; González S; Luna D
    Rev Neurol; 2000 Aug 1-15; 31(3):283-7. PubMed ID: 10996929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of neurodegeneration in neuronal ceroid-lipofuscinoses.
    Hachiya Y; Hayashi M; Kumada S; Uchiyama A; Tsuchiya K; Kurata K
    Acta Neuropathol; 2006 Feb; 111(2):168-77. PubMed ID: 16465529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuronal ceroid lipofuscinoses].
    Augestad LB; Diderichsen J
    Tidsskr Nor Laegeforen; 2006 Aug; 126(15):1908-10. PubMed ID: 16915312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary demyelination.
    Martin JJ
    Bull Soc Belge Ophtalmol; 1983 Nov; 208 Pt 1():473-8. PubMed ID: 6675832
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of seizures in a patient with Batten's disease.
    Patel NC; Davenport RD; Patel HN
    Nurse Pract; 2008 Oct; 33(10):6-9. PubMed ID: 18953233
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.